Skip to main content
. 2017 Oct 31;8(62):105407–105424. doi: 10.18632/oncotarget.22211

Table 5. Association between rs2296651 and LC, HCC in present study.

RS ID Model Genotype HC CHB LC HCC AOR1 P1 AOR2 P2 AOR3 P3 AOR4 P4
rs2296651 Alleles G 2172(89.3) 1682(98.5) 452(95.4) 229(97.9) 1 1 1 1
A 260(10.7) 26(1.5) 22(4.6) 5(2.1) 0.532 (0.328-0.861) 0.01 1.95 (1.08-3.521) 0.026 0.519 (0.273-0.99) 0.046 0.866 (0.292-2.575) 0.796
Codominant GG 956(78.6) 828(96.8) 216(90.8) 112(95.7) 1 1 1 1
GA 260(21.4) 26(3.0) 20(8.4) 5(4.3) 0.341 (0.211-0.549) 0.001 2.934 (1.607-5.358) 0.003 0.46 (0.254-0.832) 0.008 1.422 (0.535-3.778) 0.484
AA 0(0) 1(0.1) 1(0.8) 0(0) NA NA NA NA NA NA
Dominant GG+GA 1216(100) 854(99.9) 236(99.2) 117(100) 1 1 1 1
AA 0(0) 1(0.1) 1(0.8) 0(0) NA NA 2.033 (1.083-3.818) 0.027 NA NA 0.889 (0.290-2.731) 0.837
Recessive AA+GA 260(21.4) 27(3.1) 21(8.8) 5(4.3) 1 1 1 1
GG 956(78.6) 828(96.9) 216(91.2) 112(95.7) 0.499 (0.306-0.818) 0.001 2.994 (0.186-48.26) 0.44 0.52 (0.273-0.99) 0.041 NA NA
Additive 0.532 (0.328-0.861) 0.01 1.95 (1.08-3.521) 0.026 0.519 (0.273-0.99) 0.046 0.866 (0.292-2.575) 0.796

LC, liver cirrhosis. HCC, hepatocellular carcinoma. Data were presented as number (percentage) for every group. The differences in genotype frequencies between any two groups were analyzed using logistic regression models (Codominant, Recessive, Dominant, additive). Age and sex were included as covariates. AOR1 and P1, Comparison of patients with LC to HC. AOR2 and P2, Comparison of patients with LC to CHB. AOR3 and P3, Comparison of patients with HCC to HC. AOR4 and P4, Comparison of patients with HCC to CHB. AOR(95% CI), adjusted odds ratio was calculated and reported within the 95% confidence interval. Significant p-values (p < 0.05) were highlighted in bold.